首页> 外文期刊>The Lancet >Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones.
【24h】

Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones.

机译:内镜球囊扩张术与内镜括约肌切开术切除胆管结石的随机试验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Endoscopic sphincterotomy (EST) for the removal of bileduct stones is associated with acute complications and a permanent loss of biliary-sphincter function. Endoscopic balloon dilation (EBD) causes less trauma to the biliary sphincter, but may be less effective in allowing stone removal. METHODS: 218 consecutive patients with bileduct stones on endoscopic retrograde cholangiopancreatography (ERCP) were enrolled. 202 who met all eligibility criteria were randomly assigned EST or EBD. The patients were observed in hospital for at least 24 h and followed up at 1 month and 6 months. Complications were classified by an expert panel unaware of treatment allocation and outcome. Analysis was done by intention to treat. FINDINGS: After a single ERCP, all stones were removed from 92 (91%) of 101 patients assigned EST and 90 (89%) of 101 assigned EBD (p = 0.81); in nine of the latter, successful removal required additional EST. Mechanical lithotripsy was used to fragment stones in 31 EBD procedures and 13 EST procedures (p < 0.005). Early complications (before 15 days) occurred in 24 EST patients and 17 EBD patients (p = 0.29). One patient died of retroperitoneal perforation after EBD. Four patients had bleeding after EST. Seven patients in each group had pancreatitis. Complications during follow-up occurred in 23 EST patients and 18 EBD patients (p = 0.48). Acute cholecystitis was observed in seven EST patients and one EBD patient (p < 0.05). INTERPRETATION: The success rate of EBD was similar to that of EST. We found there is no evidence of the previously suggested higher risk of pancreatitis with EBD and suggest that EBD is preferred in patients at risk of bleeding after EST. Preservation of biliary-sphincter function after EBD may prevent long-term complications and reduce the risk of acute cholecystitis during follow-up. This procedure is a valuable alternative to EST in patients with bileduct stones.
机译:背景:内镜下括约肌切开术(EST)清除胆总管结石与急性并发症和胆囊括约肌功能永久丧失有关。内窥镜球囊扩张术(EBD)对胆囊括约肌的损伤较小,但在清除结石方面可能不太有效。方法:纳入218例内镜逆行胰胆管造影(ERCP)的胆总管结石患者。符合所有资格标准的202位患者被随机分配EST或EBD。在医院观察患者至少24小时,并在1个月和6个月随访。并发症由不了解治疗分配和结果的专家小组进行分类。分析是按意向进行的。结果:单次ERCP治疗后,从101名接受EST的患者中92名(91%)和101名EBD患者中的90%(89%)清除了所有结石(p = 0.81);在后者中的九个中,成功移除需要额外的EST。机械碎石术在31个EBD程序和13个EST程序中用于碎石(p <0.005)。 24例EST患者和17例EBD患者发生了早期并发症(15天之前)(p = 0.29)。 1例患者在EBD后死于腹膜后穿孔。 EST后有4例患者有出血。每组七名患者患有胰腺炎。随访期间发生并发症的有23名EST患者和18名EBD患者(p = 0.48)。在7名EST患者和1名EBD患者中观察到了急性胆囊炎(p <0.05)。解释:EBD的成功率与EST相似。我们发现没有证据表明以前建议使用EBD发生胰腺炎的风险更高,并且建议在EST后有出血风险的患者中首选EBD。 EBD后保留胆管括约肌功能可防止长期并发症并降低随访期间发生急性胆囊炎的风险。对于胆总管结石患者,此方法可替代EST。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号